GlaxoSmithKline ( (GB:GSK) ) just unveiled an announcement.
GlaxoSmithKline (GSK) announced the purchase of 500,700 of its ordinary shares as part of its ongoing buyback program, executed through Citigroup Global Markets Limited. This transaction, which involved shares priced between 1,497.00p and 1,535.00p, contributes to GSK’s strategy to manage its capital structure and return value to shareholders, with a total of 7,029,042 shares purchased since the program’s initiation.
More about GlaxoSmithKline
YTD Price Performance: 15.21%
Average Trading Volume: 7,950,313
Technical Sentiment Consensus Rating: Strong Sell
Current Market Cap: £62.51B
For an in-depth examination of GSK stock, go to TipRanks’ Stock Analysis page.